These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9534987)

  • 21. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
    Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
    Ortega-Larrocea G; Feregrino-Goyos M
    Ocul Immunol Inflamm; 1997 Dec; 5(4):279-82. PubMed ID: 9455745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR; Baldassano VF; Whitcup SM
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I; Ries E; Krepler K; Derbolav A; Rieger A; Armbruster C; Wedrich A
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytomegalovirus retinitis].
    Usui N; Usui M
    Nihon Rinsho; 1998 Jan; 56(1):197-202. PubMed ID: 9465690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cessation of anti-CMV therapy in patients with CMV retinitis.
    Dunn JP
    Hopkins HIV Rep; 1998 Mar; 10(2):11. PubMed ID: 11365137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using conjunctival swab with polymerase chain reaction to aid diagnosis of cytomegalovirus retinitis in AIDS patients.
    Liu JH; Hsu WM; Wong WW; Wang JJ; Liu WT; Liu CY; Chiou SH
    Ophthalmologica; 2000; 214(2):126-30. PubMed ID: 10720917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S; Badelon I; Chaine G
    J Fr Ophtalmol; 1998 Jan; 21(1):34-41. PubMed ID: 9834898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Margolis TP
    Surv Ophthalmol; 2000; 44(5):455. PubMed ID: 10809654
    [No Abstract]   [Full Text] [Related]  

  • 33. CMV load acts as predictor of HIV progression.
    AIDS Alert; 1997 Dec; 12(12):139-40. PubMed ID: 11364833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
    Wohl DA; Kendall MA; Owens S; Holland G; Nokta M; Spector SA; Schrier R; Fiscus S; Davis M; Jacobson MA; Currier JS; Squires K; Alston-Smith B; Andersen J; Freeman WR; Higgins M; Torriani FJ;
    HIV Clin Trials; 2005; 6(3):136-46. PubMed ID: 16192248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir.
    Berman SM; Kim RC
    Am J Med; 1994 May; 96(5):415-9. PubMed ID: 8192172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS; Patel A
    Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bilateral cystoid macular edema after successful treatment of AIDS-associated cytomegalovirus retinitis].
    Welzl-Hinterkörner E; Thölen H; Stürmer J; Opravil M; Bernauer W
    Ophthalmologe; 1999 Feb; 96(2):87-91. PubMed ID: 10095354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients.
    Schneider EW; Elner SG; van Kuijk FJ; Goldberg N; Lieberman RM; Eliott D; Johnson MW
    Retina; 2013 Oct; 33(9):1791-9. PubMed ID: 23584702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients.
    Gilbert C; Handfield J; Toma E; Lalonde R; Bergeron MG; Boivin G
    AIDS; 1998 Jan; 12(2):125-9. PubMed ID: 9468360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus retinitis: diagnosis and status of systemic therapy.
    Friedberg DN
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S1-6. PubMed ID: 9058611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.